Pillar Therapeutics, Inc.
PrivateLast Round
Seed
May 13, 2026
Momentum
Top 10%
of companies Caplight tracks
Company Overview
Pillar Therapeutics, Inc. is a biotechnology company specializing in evidence-based investing in healthcare and life sciences.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Precision Medicine, Medical Devices, Biotech Equipment
Business Model
B2B
Customer Profile
Hardware Sales, Hardware + Subscription, Services & Consulting
AI Layer
Application
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Pillar Therapeutics, Inc. Comparables
Compare Pillar Therapeutics, Inc. with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| EntroGen, Inc. | 81% | |
| Paragon Genomics | 78% | |
| Labcorp | 74% |
Pillar Therapeutics, Inc. Funding Rounds
Historical fundraising activity
Pillar Therapeutics, Inc. Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| RA Capital Management | Seed |
| UTEC (The University of Tokyo Edge Capital Partners) | Seed |
| AN Venture Partners | Seed |
Market signals
Structured signals derived from secondary market and firmographic data.
- May 13, 2026
$14M raised in Seed Round.
Recent news
Latest coverage and updates
- invests_intoOct 21, 2026
RA Cap participates in Optivolt Labs, Inc.'s $32M Series A, led by VXI Capital alongside Valo Ventures and Atlas Innovate, to expand manufacturing and bring its technology to solar systems; the financing is announced on Oct 21st '26.
- invests_intoAug 12, 2026
RA Cap participates in Expedition Therapeutics Inc.'s oversubscribed $115M Series B, led by General Atlantic with Vivo Capital and existing investors, to advance EXPD-101 through Phase 2 and expand its inflammatory-disease pipeline in California on Aug 5th '26.
Pillar Therapeutics, Inc. Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about Pillar Therapeutics, Inc.'s valuation, stock price, and market status.
Is Pillar Therapeutics, Inc. a public or private company?
Pillar Therapeutics, Inc. is a private company.
What is the current stock price of Pillar Therapeutics, Inc.?
Pillar Therapeutics, Inc. is a private company, so its shares have no public market price. Caplight tracks Pillar Therapeutics, Inc.'s secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Pillar Therapeutics, Inc. worth (valuation)?
Valuation information for Pillar Therapeutics, Inc. is not publicly available.
Can I buy Pillar Therapeutics, Inc. stock?
Pillar Therapeutics, Inc. shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Pillar Therapeutics, Inc.'s last funding round?
Pillar Therapeutics, Inc.'s most recent funding round was Seed on May 13, 2026.
Who are the main investors in Pillar Therapeutics, Inc.?
Key investors in Pillar Therapeutics, Inc. include RA Capital Management, UTEC (The University of Tokyo Edge Capital Partners), AN Venture Partners.
Will Pillar Therapeutics, Inc. IPO soon?
No public IPO plans have been announced for Pillar Therapeutics, Inc..
How can I track Pillar Therapeutics, Inc. secondary market activity?
Caplight tracks bids, offers, and trades in Pillar Therapeutics, Inc.'s shares on secondary markets.